Log In
BCIQ
Print this Print this
 

Cutasil (STP705)

  Manage Alerts
Collapse Summary General Information
Company Sirnaomics Inc.
DescriptionHistidine-lysine polymer (HKP) nanoparticle encapsulation of short interfering RNA (siRNA) targeting transforming growth factor (TGF) beta 1 (TGFB1) and cyclooxygenase-2 (COX-2)
Molecular Target Transforming growth factor (TGF) beta 1 (TGFB1) ; Cyclooxygenase-2 (COX-2)
Mechanism of Action 
Therapeutic ModalityNucleic acid: Linear RNA: siRNA

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$4.5M

$4.5M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/06/2010

$4.5M

$4.5M

0

Get a free BioCentury trial today